Increased soluble human leukocyte antigen-G levels in peripheral blood from climbers on Mount Everest

Human Immunology

Volumn 71, Issue 11, 2010, Pages 1105-1108

  Bourguignon, Michel ^a   Yaghi, Layale ^b   Flajollet, Sébastien ^b   Radanne Krawice, Irène ^b   Rouas Freiss, Nathalie ^b   Lugrin, Didier ^c   Richalet, Jean Paul ^d   Carosella, Edgardo D ^b   Moreau, Philippe ^b  

^a Autorite de Surete Nucleaire   (France)

^b DIF   (France)

^c Service d'anesthésie réanimation HÔpital de l'Archet 2   (France)

^d Centre Hospitalier Universitaire de Bobigny   (France)

Author keywords

Climbers; HLA G; Hypoxia; Mount Everest; Plasma

Indexed keywords

ANGIOGENIC FACTOR; HLA G ANTIGEN;

ADULT; ALTITUDE ACCLIMATIZATION; ARTICLE; BLOOD; BLOOD OXYGEN TENSION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPOXIA; MALE; MOUNTAINEERING; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

EID: 77957755374     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2010.08.011     Document Type: Article

References (30)

1. Patitucci M., Lugrin D., Pages G. Angiogenic/lymphangiogenic factors and adaptation to extreme altitudes during an expedition to Mount Everest. Acta Physiol (Oxf) 2009, 196:259-265.
2. Mouillot G., Marcou C., Zidi I., Guillard C., Sangrouber D., Carosella E.D., Moreau P. Hypoxia modulates HLA-G gene expression in tumor cells. Hum Immunol 2007, 68:277-285.
3. Fons P., Chabot S., Cartwright J.E., Lenfant F., L'Faqihi F., Giustiniani J., et al. Soluble HLA-G1 inhibits angiogenesis through an apoptotic pathway and by direct binding to CD160 receptor expressed by endothelial cells. Blood 2006, 108:2608-2615.
4. Brahimi-Horn M.C., Pouyssegur J. Oxygen, a source of life and stress. FEBS Lett 2007, 581:3582-3591.
5. Wilson M.H., Newman S., Imray C.H. The cerebral effects of ascent to high altitudes. Lancet Neurol 2009, 8:175-191.
6. Grocott M.P., Martin D.S., Levett D.Z., McMorrow R., Windsor J., Montgomery H.E. Arterial blood gases and oxygen content in climbers on Mount Everest. N Engl J Med 2009, 360:140-149.
7. Smith T.G., Robbins P.A., Ratcliffe P.J. The human side of hypoxia-inducible factor. Br J Haematol 2008, 141:325-334.
8. Fong G.H. Regulation of angiogenesis by oxygen sensing mechanisms. J Mol Med 2009, 87:549-560.
9. Chang C.C., Ferrone S. HLA-G in melanoma: Can the current controversies be solved?. Semin Cancer Biol 2003, 13:361-369.
10. Hunt J.S., Langat D.K., McIntire R.H., Morales P.J. The role of HLA-G in human pregnancy. Reprod Biol Endocrinol 2006, 4(Suppl 1):S10.
11. Carosella E.D., Favier B., Rouas-Freiss N., Moreau P., Lemaoult J. Beyond the increasing complexity of the immunomodulatory HLA-G molecule. Blood 2008, 111:4862-4870.
12. Park G.M., Lee S., Park B., Kim E., Shin J., Cho K., Ahn K. Soluble HLA-G generated by proteolytic shedding inhibits NK-mediated cell lysis. Biochem Biophys Res Commun 2004, 313:606-611.
13. Rouas-Freiss N., Goncalves R.M., Menier C., Dausset J., Carosella E.D. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc Natl Acad Sci U S A 1997, 94:11520-11525.
14. Mallet V., Blaschitz A., Crisa L., Schmitt C., Fournel S., King A., et al. HLA-G in the human thymus: A subpopulation of medullary epithelial but not CD83(+) dendritic cells expresses HLA-G as a membrane-bound and soluble protein. Int Immunol 1999, 11:889-898.
15. Menier C., Rabreau M., Challier J.C., Le Discorde M., Carosella E.D., Rouas-Freiss N. Erythroblasts secrete the nonclassical HLA-G molecule from primitive to definitive hematopoiesis. Blood 2004, 104:3153-3160.
16. Carosella E.D., Moreau P., Lemaoult J., Rouas-Freiss N. HLA-G: From biology to clinical benefits. Trends Immunol 2008, 29:125-132.
17. Rebmann V., Regel J., Stolke D., Grosse-Wilde H. Secretion of sHLA-G molecules in malignancies. Semin Cancer Biol 2003, 13:371-377.
18. Baricordi O.R., Stignani M., Melchiorri L., Rizzo R. HLA-G and inflammatory diseases. Inflamm Allergy Drug Targets 2008, 7:67-74.
19. Menier C., Guillard C., Cassinat B., Carosella E.D., Rouas-Freiss N. HLA-G turns off erythropoietin receptor signaling through JAK2 and JAK2 V617F dephosphorylation: Clinical relevance in polycythemia vera. Leukemia 2008, 22:578-584.
20. Moreau P., Flajollet S., Carosella E.D. Non-classical transcriptional regulation of HLA-G: An update. J Cell Mol Med 2009, 13:2973-2989.
21. Simon M.C., Keith B. The role of oxygen availability in embryonic development and stem cell function. Nat Rev Mol Cell Biol 2008, 9:285-296.
22. Pouyssegur J., Dayan F., Mazure N.M. Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 2006, 441:437-443.
23. Rebmann V., Lemaoult J., Rouas-Freiss N., Carosella E.D., Grosse-Wilde H. Report of the Wet Workshop for Quantification of Soluble HLA-G in Essen. Hum Immunol 2004, 66:853-863.
24. Rodesch F., Simon P., Donner C., Jauniaux E. Oxygen measurements in endometrial and trophoblastic tissues during early pregnancy. Obstet Gynecol 1992, 80:283-285.
25. McMaster M., Zhou Y., Shorter S., Kapasi K., Geraghty D., Lim K.H., Fisher S. HLA-G isoforms produced by placental cytotrophoblasts and found in amniotic fluid are due to unusual glycosylation. J Immunol 1998, 160:5922-5928.
26. Ginouves A., Ilc K., Macias N., Pouyssegur J., Berra E. PHDs overactivation during chronic hypoxia "desensitizes" HIFalpha and protects cells from necrosis. Proc Natl Acad Sci U S A 2008, 105:4745-4750.
27. Walmsley S.R., Print C., Farahi N., Peyssonnaux C., Johnson R.S., Cramer T., et al. Hypoxia-induced neutrophil survival is mediated by HIF-1alpha-dependent NF-kappaB activity. J Exp Med 2005, 201:105-115.
28. Zidi I., Guillard C., Marcou C., Krawice-Radanne I., Sangrouber D., Rouas-Freiss N., et al. Increase in HLA-G1 proteolytic shedding by tumor cells: A regulatory pathway controlled by NF-kappaB inducers. Cell Mol Life Sci 2006, 63:2669-2681.
29. Pistoia V., Morandi F., Wang X., Ferrone S. Soluble HLA-G: Are they clinically relevant?. Semin Cancer Biol 2007, 17:469-479.
30. Larsen M.H., Hviid T.V. Human leukocyte antigen-G polymorphism in relation to expression, function, and disease. Hum Immunol 2009, 70:1026-1034.